4 hours work starting work on an animation for Fioh's animation jam.
I've not storyboarded shit and am winging it and have like 4 days to make a proper animation.
Spoilers below on what it'll be.
4 hours work starting work on an animation for Fioh's animation jam.
I've not storyboarded shit and am winging it and have like 4 days to make a proper animation.
Spoilers below on what it'll be.
That's where the guilt was coming from whxksgdhdh
BUT they're comics-y and I'll be excited to have you see when It's Time
That's where the guilt was coming from whxksgdhdh
#Land Rover #Discovery #MED17.9.7 SW:GK72-14C204-MYB 10SW008524 В прошивке сделано: Euro2 EVAPoff
https://easytuningshop.ru/list/products/land-rover-discovery-med17-9-7-gk72-14c204-myb-10sw008524---19554
#Land Rover #Discovery #MED17.9.7 SW:GK72-14C204-MYB 10SW008524 В прошивке сделано: Euro2 EVAPoff
https://easytuningshop.ru/list/products/land-rover-discovery-med17-9-7-gk72-14c204-myb-10sw008524---19554
Also side note Imu's colors coming soon myb even next week at weekend 😳😳 AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
Also side note Imu's colors coming soon myb even next week at weekend 😳😳 AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
R2R3-MYB ClMS188 directly activates ClMS1L1 to orchestrate tapetum development; clms188 mutants are fully male sterile, aiding watermelon hybrid seed production.
Details: https://www.maxapress.com/article/doi/10.48130/seedbio-0026-0020
#Watermelon #Tapetum #TranscriptionFactor
R2R3-MYB ClMS188 directly activates ClMS1L1 to orchestrate tapetum development; clms188 mutants are fully male sterile, aiding watermelon hybrid seed production.
Details: https://www.maxapress.com/article/doi/10.48130/seedbio-0026-0020
#Watermelon #Tapetum #TranscriptionFactor
On November 19, 2026, Remix Therapeutics, Inc. issued a press release announcing updated Phase 1 data from its ongoing ARIA Phase 1/2 clinical trial of REM-422, an oral MYB mRNA degrader, in patients with adenoid cystic carcinoma , in a late-breaking oral presentation at the 2026 EORTC-NC...
On November 19, 2026, Remix Therapeutics, Inc. issued a press release announcing updated Phase 1 data from its ongoing ARIA Phase 1/2 clinical trial of REM-422, an oral MYB mRNA degrader, in patients with adenoid cystic carcinoma , in a late-breaking oral presentation at the 2026 EORTC-NC...
onlinelibrary.wiley.com/doi/10.1111/...
#PlantSci @jipb.bsky.social @wileylifesci.bsky.social @plantgenetics.bsky.social @planteditors.bsky.social @cropsci.bsky.social @plant-sci.bsky.social @sciplant.bsky.social
Ok, I don't think I'm only one to have thought of it
Ok, I don't think I'm only one to have thought of it
Hey there! this lightning-fast demon is my very first OC in 1972 Devilman anime and when I first watch the series, It's very interesting and I hope you guys liked this 😊
Deviantart Link:
www.deviantart.com/myb-1228/art...
#DevilmanOc
Hey there! this lightning-fast demon is my very first OC in 1972 Devilman anime and when I first watch the series, It's very interesting and I hope you guys liked this 😊
Deviantart Link:
www.deviantart.com/myb-1228/art...
#DevilmanOc
#RemixTherapeutics #PrecisionMedicine
#RemixTherapeutics #PrecisionMedicine
🎯#OpenAccess
🔗 doi.org/10.1111/jipb...
@wileylifesci.bsky.social
#PlantSci #JIPB #CropSci
🎯#OpenAccess
🔗 doi.org/10.1111/jipb...
@wileylifesci.bsky.social
#PlantSci #JIPB #CropSci
myb i just woke up
myb i just woke up